Substrate
Topic

oncology drugs

1 stories related to this topic, newest first.

Gilead Sciences Acquires German Biotech Tubulis for Over $3 BillionAnna Zvereva from Tallinn, Estonia / Wikimedia (CC BY-SA 2.0)
science28 days ago

Gilead Sciences Acquires German Biotech Tubulis for Over $3 Billion

Gilead Sciences announced the acquisition of Tubulis, a German biotechnology company, for more than $3 billion. The deal aims to expand Gilead's oncology drug development pipeline. Tubulis specializes in antibody-drug conjugates for cancer treatments.

ST
1 source